Pantoprazol Amarox (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Amarox, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat acid‑related conditions in adults.

GNH USA supplies Pantoprazol Amarox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Amarox is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related gastrointestinal disorders: - Gastro‑esophageal reflux disease (GERD): provides relief of heartburn and promotes healing of the esophageal lining. - Erosive esophagitis: accelerates healing of erosions caused by acid exposure. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with this rare tumor condition. - Peptic ulcer disease (duodenal and gastric ulcers): supports ulcer healing and reduces recurrence risk. - Maintenance therapy for healed erosive oesophageal lesions: helps prevent relapse after initial healing.

Pantoprazol Amarox may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: typically self‑limiting. - Nausea: occasional and transient. - Abdominal pain or discomfort. - Flatulence: excess gas formation. - Constipation: infrequent but reported.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile‑associated colitis: watery diarrhea, abdominal cramping. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Acute interstitial nephritis: kidney inflammation presenting with reduced urine output. - Fracture risk with long‑term use: decreased bone mineral density. - Liver enzyme elevation: abnormal liver function tests.

When prescribing Pantoprazol Amarox, clinicians should consider several safety aspects: - Assess renal function: adjust use in patients with severe impairment. - Monitor magnesium levels: especially during prolonged therapy. - Evaluate bone health: consider calcium/vitamin D supplementation for long‑term users. - Review concomitant medications: potential for altered absorption of drugs requiring acidic pH. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Pantoprazol Amarox can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid): - Ketoconazole or itraconazole: reduced antifungal absorption. - Atazanavir: markedly decreased antiviral exposure. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR values. - Methotrexate: elevated serum concentrations, especially in renal impairment. - Digoxin: modest rise in plasma levels. - Iron supplements: decreased iron absorption when taken simultaneously.